Salt substitute
Salt substitute has been studied in 8 papers since 2023: 3 trials in people, 4 reviews; 3 in the past year. The newest paper, Jan 30, 2026: “Comparative Effects of Non-Pharmacological Interventions for Stroke Prevention in Adults: A Network Meta-Analysis”.
8 papers study it13 findingsUpdated
See all 8 papers on salt substitute
At a glance
Independent labs found the same change in people. 5 independent labs in 5 countries.
“Use of salt substitute compared to regular salt had no detectable effect on the incidence of fracture”
1 of its findings points the other way.
- 5 independent labs in 5 countries
- 1 finding against
- Funders: Ministry of Science and Technology of the People's Republic of China and 8 more
- Human trial3
Studies in people
3 studies gave salt substitute to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
no change: Has no effect on fracture incidenceRate ratio 0.96; 95% CI 0.81 to 1.14 | Randomized trial5 years | 20,995 people | BMC medicine, Sep 4, 2024 |
down: Lowers the risk of hypertensionadjusted HR: 0.60; 95% CI: 0.39 to 0.92; P = 0.02 no change: Has no effect on hypotension9.0 vs 9.7 per 100 person-years; P = 0.76 down: Decreases systolic blood pressure-8.0 mm Hg (95% CI: -12.4 to -3.7 mm Hg) | Randomized trial2 years | olderOlder adults; normotensive | Journal of the American College of Cardiology, Feb 15, 2024 |
down: Decreases systolic blood pressure-7.1 mmHg (95% CI -10.5 to -3.8) down: Lowers the risk of cardiovascular eventsHR 0.60, 95% CI 0.38-0.96 no change: Has no effect on mortalityHR 0.84, 95% CI 0.63-1.13 | Randomized trial2 years | 1,612 peopleBoth55 years or olderOlder adults | Nature medicine, Apr 13, 2023 |
What did studies of salt substitute find?
6Studies of salt substitute measured 6 outcomes, among them systolic blood pressure, systolic blood pressure and mortality.
Systolic blood pressure
downin humans2
2 studies
Systolic blood pressure
downin humans2
Salt substitute decreases systolic blood pressure in humans (normotensive) (-8.0 mm Hg (95% CI: -12.4 to -3.7 mm Hg)).
“resulting in a net reduction of -8.0 mm Hg (95% CI: -12.4 to -3.7 mm Hg) in systolic and -2.0 mm Hg (95% CI: -4.1 to 0.1 mm Hg) in diastolic blood pressure between intervention groups”
Human trialnormotensive2 years
Effect of a Salt Substitute on Incidence of Hypertension and Hypotension Among Normotensive Adults
Journal of the American College of Cardiology
Salt substitute decreases systolic blood pressure in humans (Elevated blood pressure; compared with no intervention) (-6.78 mmHg (95% CI -8.42 to -5.14) versus no intervention; -5.35 mmHg (95% CI -7.89 to -2.81) versus conventional health education).
“salt substitutes was ranked the most effective intervention in the network meta-analysis, with reductions of -6.78 mmHg (95% CI, -8.42, -5.14) compared to no intervention”
ReviewElevated blood pressure; compared with no intervention
Nutrients
Systolic blood pressure
downin humans2
2 studies
Systolic blood pressure
downin humans2
Salt substitute decreases systolic blood pressure in humans (-7.1 mmHg (95% CI -10.5 to -3.8)).
“Salt substitute compared with usual salt lowered systolic blood pressure (-7.1 mmHg, 95% confidence interval (CI) -10.5 to -3.8)”
Human trial2 years
Nature medicine
Salt substitute decreases systolic blood pressure in humans (Compared with regular salt) (4.39–4.64 mmHg reduction).
“moderate-potassium and low-sodium salt substitutes (25-40% KCl, 60-79% NaCl) probably reduce all-cause mortality, cardiovascular mortality, non-fatal cardiovascular events and systolic blood pressure (SBP) compared to regular salt”
ReviewCompared with regular salt25-40% KCl, 60-79% NaCl
BMC medicine
Mortality
downin humans1no changein humans1HR 0.84
2 studies
Mortality
downin humans1no changein humans1HR 0.84
Salt substitute showed no clear effect on mortality in humans (HR 0.84, 95% CI 0.63-1.13).
“had no effect on total mortality (HR 0.84, 95% CI 0.63-1.13)”
Human trial2 years
Nature medicine
Salt substitute decreases mortality in humans (Compared with regular salt; evidence predominantly driven by SSaSS) (7–17 fewer deaths per 1000 individuals across mortality outcomes).
“moderate-potassium and low-sodium salt substitutes (25-40% KCl, 60-79% NaCl) probably reduce all-cause mortality, cardiovascular mortality, non-fatal cardiovascular events and systolic blood pressure (SBP) compared to regular salt”
ReviewCompared with regular salt; evidence predominantly driven by SSaSS25-40% KCl, 60-79% NaCl
BMC medicine
Nonfatal cardiovascular events
downin humans1
1 study
Nonfatal cardiovascular events
downin humans1
Salt substitute decreases nonfatal cardiovascular events in humans (Compared with regular salt; evidence predominantly driven by SSaSS).
“moderate-potassium and low-sodium salt substitutes (25-40% KCl, 60-79% NaCl) probably reduce all-cause mortality, cardiovascular mortality, non-fatal cardiovascular events and systolic blood pressure (SBP) compared to regular salt”
ReviewCompared with regular salt; evidence predominantly driven by SSaSS25-40% KCl, 60-79% NaCl
BMC medicine
Fracture incidence
no changein humans1
1 study
Fracture incidence
no changein humans1
Salt substitute showed no clear effect on fracture incidence in humans (Rate ratio 0.96; 95% CI 0.81 to 1.14).
“Use of salt substitute compared to regular salt had no detectable effect on the incidence of fracture”
Human trialCompared with regular salt in a population at high risk of cardiovascular disease and fracture5 yearsn = 20,995
BMC medicine
Hypotension
no changein humans1
1 study
Hypotension
no changein humans1
Salt substitute showed no clear effect on hypotension in humans (normotensive) (9.0 vs 9.7 per 100 person-years; P = 0.76).
“did not increase incidence of hypotension episodes (9.0 vs 9.7 per 100 person-years; P = 0.76)”
Human trialnormotensive2 years
Effect of a Salt Substitute on Incidence of Hypertension and Hypotension Among Normotensive Adults
Journal of the American College of Cardiology
What is salt substitute linked with?
4Studies link salt substitute with 4 measures, among them fatal stroke, hypertension and hyperkalemia.
Fatal stroke
downin humans1RR 0.78
1 study
Fatal stroke
downin humans1RR 0.78
Salt substitute lowers the risk of fatal stroke in humans (RR = 0.78; 95% CI: 0.68-0.90).
“Only Salt substitute showed significantly reduced fatal stroke risk (RR = 0.78; 95% CI: 0.68-0.90; high SOE).”
Review
Cerebrovascular diseases (Basel, Switzerland)
Hypertension
downin humans1HR 0.6
1 study
Hypertension
downin humans1HR 0.6
Salt substitute lowers the risk of hypertension in humans (normotensive) (adjusted HR: 0.60; 95% CI: 0.39 to 0.92; P = 0.02).
“Compared with usual salt group (n = 298), the salt substitute group (n = 313) had a lower hypertension incidence (11.7 vs 24.3 per 100 person-years; adjusted HR: 0.60; 95% CI: 0.39 to 0.92; P = 0.02)”
Human trialnormotensive2 years
Effect of a Salt Substitute on Incidence of Hypertension and Hypotension Among Normotensive Adults
Journal of the American College of Cardiology
Hyperkalemia
upin humans1
1 study
Hyperkalemia
upin humans1
Salt substitute raises the risk of hyperkalemia in humans.
“salt substitute increased mean serum potassium and led to more frequent biochemical hyperkalemia”
Human trial2 years
Nature medicine
Cardiovascular events
downin humans1HR 0.6
1 study
Cardiovascular events
downin humans1HR 0.6
Salt substitute lowers the risk of cardiovascular events in humans (HR 0.60, 95% CI 0.38-0.96).
“resulted in fewer cardiovascular events (hazard ratio (HR) 0.60, 95% CI 0.38-0.96)”
Human trial2 years
Nature medicine